Sensitive targeted multiple protein quantification based on elemental detection of Quantum Dots

[Display omitted] •Novel generic platform for multiparametric quantification of proteins.•QDs labeling and ICP-MS detection allow significant analytical signal amplification.•ICP-MS mass balances information provided an internal validation of the immunoassay.•Multiparametric determination of 5 prote...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytica chimica acta 2015-06, Vol.879, p.77-84
Hauptverfasser: Montoro Bustos, Antonio R., Garcia-Cortes, Marta, González-Iglesias, Hector, Ruiz Encinar, Jorge, Costa-Fernández, José M., Coca-Prados, Miguel, Sanz-Medel, Alfredo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Novel generic platform for multiparametric quantification of proteins.•QDs labeling and ICP-MS detection allow significant analytical signal amplification.•ICP-MS mass balances information provided an internal validation of the immunoassay.•Multiparametric determination of 5 proteins in human serum samples.•ICP-MS reduced matrix effects as compared to other conventional detection techniques. A generic strategy based on the use of CdSe/ZnS Quantum Dots (QDs) as elemental labels for protein quantification, using immunoassays with elemental mass spectrometry (ICP-MS), detection is presented. In this strategy, streptavidin modified QDs (QDs-SA) are bioconjugated to a biotinylated secondary antibody (b-Ab2). After a multi-technique characterization of the synthesized generic platform (QDs-SA-b-Ab2) it was applied to the sequential quantification of five proteins (transferrin, complement C3, apolipoprotein A1, transthyretin and apolipoprotein A4) at different concentration levels in human serum samples. It is shown how this generic strategy does only require the appropriate unlabeled primary antibody for each protein to be detected. Therefore, it introduces a way out to the need for the cumbersome and specific bioconjugation of the QDs to the corresponding specific recognition antibody for every target analyte (protein). Results obtained were validated with those obtained using UV–vis spectrophotometry and commercial ELISA Kits. As expected, ICP-MS offered one order of magnitude lower DL (0.23fmol absolute for transferrin) than the classical spectrophotometric detection (3.2fmol absolute). ICP-MS precision and detection limits, however turned out to be compromised by procedural blanks. The full analytical performance of the ICP-MS-based immunoassay proposed was assessed for detection of transferrin (Tf), present at the low ngmL−1 range in a complex “model” synthetic matrix, where the total protein concentration was 100μgmL−1. Finally, ICP-MS detection allowed the quantitative control of all the steps of the proposed immunoassay, by computing mass balances obtained, and the development of a faster indirect immunoassay format where the plate wells were directly coated with the whole protein mixture sample.
ISSN:0003-2670
1873-4324
DOI:10.1016/j.aca.2015.03.015